BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 19296250)

  • 1. [Analysis of clinicopathology and prognosis in 181 patients with gastrointestinal stromal tumors].
    Zhang Y; Cao H; Wang M; Shen DP; Shen ZY; Ni XZ; Wu ZY; Shen YY; Liu Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):150-4. PubMed ID: 19296250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of gastrointestinal stromal tumors].
    Zhang W; Ye ZY; Shao QS; Zhao ZS; Wang YD; Xu XD
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):378-81. PubMed ID: 19598024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of prognostic factors for patients with gastrointestinal stromal tumors].
    Jie ZG; Xie XP; Qin KW; Liu Y; Li ZR; Dai AB; Yao YX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):210-2. PubMed ID: 16167229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
    Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
    Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
    Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
    Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
    Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
    Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An audit of surgical management of gastrointestinal stromal tumours (GIST).
    Bucher P; Egger JF; Gervaz P; Ris F; Weintraub D; Villiger P; Buhler LH; Morel P
    Eur J Surg Oncol; 2006 Apr; 32(3):310-4. PubMed ID: 16414236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 63 cases with gastric gastrointestinal stromal tumors].
    Rong L; Wan YL; Nian WD; Liu P; Liang JY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):24-7. PubMed ID: 19145498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment for primary gastrointestinal stromal tumors: a report of 73 cases].
    Zhang W; Shao QS; Ye ZY; Zhao ZS; Wang YD; Zhu YW
    Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(2):98-101. PubMed ID: 19563001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours.
    Aparicio T; Boige V; Sabourin JC; Crenn P; Ducreux M; Le Cesne A; Bonvalot S
    Eur J Surg Oncol; 2004 Dec; 30(10):1098-103. PubMed ID: 15522557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors in gastrointestinal stromal tumors among a group of Mexican patients].
    Medina-Franco H; Aguilar-Jiménez JR; Medina-Cuairán JZ
    Gac Med Mex; 2009; 145(2):91-6. PubMed ID: 19518014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of gastrointestinal stromal tumors of the stomach: report of 28 cases.
    Wu Y; Zhu X; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):15-21. PubMed ID: 17311865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases.
    Otani Y; Furukawa T; Yoshida M; Saikawa Y; Wada N; Ueda M; Kubota T; Mukai M; Kameyama K; Sugino Y; Kumai K; Kitajima M
    Surgery; 2006 Apr; 139(4):484-92. PubMed ID: 16627057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of gastrointestinal stromal tumor: a report of 29 patients].
    Qin HD; Zhang DW; Yang WL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):139-41. PubMed ID: 16555155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the postoperative course in cases of GIST of the stomach. The efficacy of imatinib in cases of recurrence.
    Higashi D; Watanabe Y; Hirano K; Shimomura T; Egawa Y; Tomiyasu T; Ishibashi Y; Futami K; Maekawa T; Ota A; Oshige K; Iwashita A
    Anticancer Res; 2009 Nov; 29(11):4893-6. PubMed ID: 20032453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of adjuvant post-surgical therapy with imatinib in gastrointestinal stromal tumor patients with high risk of recurrence: interim analysis from a multicenter prospective clinical trial].
    Zhan WH; Wang PZ; Shao YF; Wu XT; Gu J; Li R; Wan DS; Ding KF; Shi YQ; Yu JR; Lu HS; Zou XM; Bi JW; Sun YH; Lu YF; Chen DD; Zhang XH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):383-7. PubMed ID: 17043955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
    Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.